ZyCoV-D to Get Permission For Emergency Use This Week
Zydus Cadila‘s Covid-19 vaccine ZyCoV-D is getting a nod for emergency use in India by this week. Union Health Minister Mansukh Mandaviya in the Rajya...
Tag : Sputnik V
Zydus Cadila Applies for Emergency Use of Covid-19 Vaccine
Indian drugmaker Zydus Cadila has applied to the Central Drugs Standard Control Organisation (CDSCO) for emergency use approval of its Covid-19 vaccine, which showed a...
Cipla Gets DGCI Permission to Import Moderna’s Vaccine
Cipla, a multinational pharmaceutical company headquartered in Mumbai, on Tuesday received approval from the Drugs Controller General of India (DCGI) to import Moderna’s coronavirus vaccine...
DCGI Approves SII to Manufacture Sputnik V in India
The Drugs Controller General of India (DCGI) has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik V Covid-19 vaccine in...
India to Waive Import Duty on Covid-19 Vaccine
The government is likely to waive a 10 per cent customs duty levied on imported vaccines in a bid to keep low the cost of...
Delivery of Russian Sputnik in India to Start in April
Indian Ambassador to Russia, Bala Venkatesh Varma on Thursday said that the first batch of Russia’s Covid-19 vaccine Sputnik V will be delivered to India...
DCGI Approves Use of Sputnik V Vaccine
The Drug Controller General of India (DCGI) has approved the restricted emergency use of the Sputnik V vaccine late Monday night. With this, India now...
India Orders 14.5 Million Covid-19 Vaccine Doses
India has ordered 10 million more doses of the AstraZeneca COVID-19 vaccine from the Serum Institute of India (SII) and 4.5 million more of a homegrown one...
India To Approve Sputnik V Vaccine For Use Soon
India is expected to grant emergency use authorization for Russia’s Sputnik V COVID-19 vaccine this month or next, the Russian Direct Investment Fund (RDIF), which markets the...
Sputnik V is 91.4% Effective, Says Vaccine Developers
Russia’s Sputnik V vaccine is 91.4 per cent effective in protecting COVID-19 and has demonstrated 100 per cent efficacy against severe coronavirus cases, the vaccine’s developers said...